Ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
torsades	torsades	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
without	without	O	O	O	O
concomitant	concomitant	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
QT	qt	O	O	O	O
interval-prolonging	interval-prolonging	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

Ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
known	known	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
proarrhythmic	proarrhythmic	O	O	O	O
without	without	O	O	O	O
concomitant	concomitant	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
QT	qt	O	O	O	O
interval-prolonging	interval-prolonging	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
woman	woman	O	O	O	O
with	with	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
who	who	O	O	O	O
developed	developed	O	O	O	O
a	a	O	O	O	O
markedly	markedly	O	O	O	O
prolonged	prolonged	O	O	OTHERS	I
QT	qt	O	O	OTHERS	I
interval	interval	O	O	OTHERS	I
and	and	O	O	O	O
torsades	torsades	O	DISEASE	OTHERS	I
de	de	O	DISEASE	OTHERS	I
pointes	pointes	O	DISEASE	OTHERS	I
(	(	O	O	O	O
TdP	tdp	O	DISEASE	OTHERS	I
)	)	O	O	O	O
after	after	O	O	O	O
taking	taking	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
fungal	fungal	O	O	OTHERS	I
infection	infection	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Her	her	O	O	O	O
QT	qt	O	O	O	O
interval	interval	O	O	O	O
returned	returned	O	O	O	O
to	to	O	O	O	O
normal	normal	O	O	O	O
upon	upon	O	O	O	O
withdrawal	withdrawal	O	O	O	O
of	of	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Genetic	genetic	O	O	O	O
study	study	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
find	find	O	O	O	O
any	any	O	O	O	O
mutation	mutation	O	O	O	O
in	in	O	O	O	O
her	her	O	O	O	O
genes	genes	O	O	O	O
that	that	O	O	O	O
encode	encode	O	O	O	O
cardiac	cardiac	O	O	O	O
IKr	ikr	O	O	O	O
channel	channel	O	O	O	O
proteins	proteins	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
postulate	postulate	O	O	O	O
that	that	O	O	O	O
by	by	O	O	O	O
virtue	virtue	O	O	O	O
of	of	O	O	O	O
its	its	O	O	O	O
direct	direct	O	O	O	O
blocking	blocking	O	O	O	O
action	action	O	O	O	O
on	on	O	O	O	O
IKr	ikr	O	O	O	O
,	,	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
alone	alone	O	O	O	O
may	may	O	O	O	O
prolong	prolong	O	O	O	O
QT	qt	O	O	O	O
interval	interval	O	O	O	O
and	and	O	O	O	O
induce	induce	O	O	O	O
TdP.	tdp.	O	O	O	O
This	this	O	O	O	O
calls	calls	O	O	O	O
for	for	O	O	O	O
attention	attention	O	O	O	O
when	when	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
administered	administered	O	O	O	O
to	to	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
for	for	O	O	O	O
acquired	acquired	O	O	O	O
long	long	O	DISEASE	OTHERS	I
QT	qt	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

